JMI Syringes & Medical Devices (DHA:JMISMDL) EBIT: BDT173 Mil (TTM As of Mar. 2025)


DHA:JMISMDL JMI Syringes & Medical Devices Ltd DHA:JMISMDL
75 GF Score
Price BDT139.30
View Full Analysis

What is JMI Syringes & Medical Devices EBIT?

JMI Syringes & Medical Devices DHA:JMISMDL -0.43% 75 EBIT is BDT173 Mil as of Mar. 2025. GuruFocus rates DHA:JMISMDL with a GF Score™ of 75/100.

JMI Syringes & Medical Devices's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2025 was BDT14 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2025 was BDT173 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. JMI Syringes & Medical Devices's annualized ROC % for the quarter that ended in Mar. 2025 was 0.00%. JMI Syringes & Medical Devices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 2.12%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. JMI Syringes & Medical Devices's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 4.17%.


JMI Syringes & Medical Devices  (DHA:JMISMDL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

JMI Syringes & Medical Devices's annualized ROC % for the quarter that ended in Mar. 2025 is calculated as:

ROC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=53.272 * ( 1 - 100% )/( (2785.928 + 2838.022)/ 2 )
=0/2811.975
=0.00 %

where

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3007.317 - 124.854 - ( 96.535 - max(0, 280.674 - 1648.414+96.535))
=2785.928

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3058.033 - 122.9 - ( 97.111 - max(0, 333.162 - 1711.123+97.111))
=2838.022

Note: The Operating Income data used here is four times the quarterly (Mar. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

JMI Syringes & Medical Devices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Mar. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=56.56/( ( (1356.432 + max(1297.237, 0)) + (1344.44 + max(1343.586, 0)) )/ 2 )
=56.56/( ( 2653.669 + 2688.026 )/ 2 )
=56.56/2670.8475
=2.12 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(672.091 + 589.352 + 290.436) - (124.854 + 0 + 129.788)
=1297.237

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(652.247 + 650.231 + 311.534) - (122.9 + 0 + 147.526)
=1343.586

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

JMI Syringes & Medical Devices's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2025 )
=173.076/4152.812
=4.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JMI Syringes & Medical Devices EBIT Related Terms


JMI Syringes & Medical Devices EBIT Historical Data

* Premium members only.

The historical data trend for JMI Syringes & Medical Devices's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices EBIT Chart

JMI Syringes & Medical Devices Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 220.88 197.35 220.90 77.40 133.59

JMI Syringes & Medical Devices Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.57 66.94 40.23 51.77 14.14

DHA:JMISMDL vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JMI Syringes & Medical Devices EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where JMI Syringes & Medical Devices's EV-to-EBIT falls into.


DHA:JMISMDL
75GF Score
JMI Syringes & Medical Devices Ltd DHA:JMISMDL
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JMI Syringes & Medical Devices EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT173 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of BDT173 Mil mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a EBIT of BDT173 Mil as of Mar. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on JMI Syringes & Medical Devices.
Is JMI Syringes & Medical Devices' EBIT too high?
JMI Syringes & Medical Devices' current EBIT is BDT173 Mil. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' EBIT compare to ISRG and BDX?
JMI Syringes & Medical Devices' EBIT of BDT173 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on JMI Syringes & Medical Devices. JMI Syringes & Medical Devices's current EBIT is BDT173 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current EBIT of BDT173 Mil. The current EBIT is BDT173 Mil. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current EBIT is BDT173 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JMI Syringes & Medical Devices Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score

Get the complete analysis for DHA:JMISMDL

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT139.30
Price